ANALISIS PERBANDINGAN KINERJA KEUANGAN PERUSAHAAN FARMASI MILIK BUMN DAN SWASTA
DOI:
https://doi.org/10.33603/jibm.v1i1.486Keywords:
kinerja keuangan, ROE, EPS, EVAAbstract
Abstract. This research as a purpose to comparative analysis of financial performance in the pharmacy state owned corporation with private corporation listed in Indonesian Stock Exchange during 2010-2014 periods. The methodologies of Reseach is descriptive compatative, sampling used was 8 companies listed in ISE for 5 periods. Analysis technique used was Independen sample T-test. The Result of analysis show that comparative of financial performance in the pharmacy state owned corporation with private corporation base on ROE is be found significantly differentiation because the private corporation ROE is safe position on 15%, where as state owned corporation ROE is under safe position. If looked base on EPS is be found significantly differentiation between pharmacy state owned corporation with private corporation because private corporate EPS better than state owned corporate. For EVA value the pharmacy state owned corporation with private corporation not be found significantly differentiation because the second corporate have EVA negative.
Keywords. financial performance; ROE; EPS; EVA
Â
Abstrak. Penelitian ini bertujuan untuk menganalisis perbandingan kinerja keuangan perusahaan farmasi milik BUMN dan Swasta yang terdaftar di Bursa Efek Indonesia dari tahun 2010 – 2014. Metode penelitian yang digunakan deskriptif komparatif, dengan sampel 8 perusahaan farmasi yang terdaftar di BEI selama 5 tahun. Sementara teknik pengolahan data menggunakan Independen sample T-test. Hasil penelitian menunjukkan bahwa Perbandingan kinerja keuangan perusahaan farmasi milik BUMN dan Swasta berdasarkan ROE terdapat perbedaan yang signifikan karena ROE milik swasta ada di posisi aman dengan persentase diatas 15%, sementara persentase ROE perusahaan farmasi BUMN masih dibawah posisi aman. Apabila dilihat berdasarkan EPS terdapat perbedaan signifikan antara EPS perusahaan farmasi milik BUMN dan swasta karena laba per lembar saham milik perusahaan farmasi Swasta rata-ratanya jauh lebih tinggi dari perusahaan BUMN. Namun untuk nilai EVA perusahaan farmasi BUMN dan swasta tidak terdapat perbedaan yang signifikan karena kedua jenis perusahaan ini sama-sama memiliki nilai EVA negatif.
Katakunci. kinerja keuangan; ROE; EPS; EVA
References
Bambang Riyanto. (2014). Dasar-Dasar Pembelanjaan Perusahaan. Yogyakarta: BPFE.
Darmadji. (2006). Pasar Modal di Indonesia, Edisi 2. Jakarta: Salemba Empat.
Fahmi, I. (2011). Analisis Kinerja Keuangan. Bandung: Alfabeta.
Hanafi dan Halim. (2014). Analisis Laporan Keuangan Edisi Keempat (STIM YKPN). Yogyakarta.
Harahap. (2013). Analisis Laporan Keuangan. Jakarta: Grafindo.
Kasmir. (2014). Analisis Laporan Keuangan. Jakarta: PT Raja Grafindo.
Munawir. (2014). Analisis Laporan Keuangan. Yogyakarta: Liberty.
Suad Husnan, E. P. (2015). Dasar-dasar Manajemen Keuangan. UPP AMP.
Sugiyono. (2011). Metode Penelitian Bisnis. Bandung: Alfabeta.
Downloads
Published
How to Cite
Issue
Section
Citation Check
License
Copyright Notice
Copyright notice:
- Authors grants the copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
